These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7830280)

  • 1. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker.
    Bridger GJ; Skerlj RT; Thornton D; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Yamamoto N; De Vreese K; Pauwels R
    J Med Chem; 1995 Jan; 38(2):366-78. PubMed ID: 7830280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Struyf S; Witvrouw M; Schols D; De Clercq E
    J Med Chem; 1999 Sep; 42(19):3971-81. PubMed ID: 10508445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclams.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Joao HC; Witvrouw M; De Vreese K; Pauwels R; De Clercq E
    J Med Chem; 1996 Jan; 39(1):109-19. PubMed ID: 8568797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100.
    De Clercq E; Yamamoto N; Pauwels R; Balzarini J; Witvrouw M; De Vreese K; Debyser Z; Rosenwirth B; Peichl P; Datema R
    Antimicrob Agents Chemother; 1994 Apr; 38(4):668-74. PubMed ID: 7913308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structural activity relationship study of bis-tetraazacyclic compounds. A novel series of HIV-1 and HIV-2 inhibitors.
    Joao HC; De Vreese K; Pauwels R; De Clercq E; Henson GW; Bridger GJ
    J Med Chem; 1995 Sep; 38(19):3865-73. PubMed ID: 7562918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and structure relationships of new N,N',N",N"'-tetrakis (omega-amino alkyl) tetraazamacrocycles.
    Trabaud C; Dessolin J; Camplo M; Hantz O; Zoulim F; Borel C; Meyer M; Pepe G; Chermann JC; Kraus JL
    Antivir Chem Chemother; 1998 Jan; 9(1):73-84. PubMed ID: 9875379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication.
    Bridger GJ; Skerlj RT; Hernandez-Abad PE; Bogucki DE; Wang Z; Zhou Y; Nan S; Boehringer EM; Wilson T; Crawford J; Metz M; Hatse S; Princen K; De Clercq E; Schols D
    J Med Chem; 2010 Feb; 53(3):1250-60. PubMed ID: 20043638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, stability, antiviral activity, and protease-bound structures of substrate-mimicking constrained macrocyclic inhibitors of HIV-1 protease.
    Tyndall JD; Reid RC; Tyssen DP; Jardine DK; Todd B; Passmore M; March DR; Pattenden LK; Bergman DA; Alewood D; Hu SH; Alewood PF; Birch CJ; Martin JL; Fairlie DP
    J Med Chem; 2000 Sep; 43(19):3495-504. PubMed ID: 11000004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
    De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc(II) complexes of constrained antiviral macrocycles.
    Ross A; Choi JH; Hunter TM; Pannecouque C; Moggach SA; Parsons S; De Clercq E; Sadler PJ
    Dalton Trans; 2012 Jun; 41(21):6408-18. PubMed ID: 22466936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV.
    Clanton DJ; Buckheit RW; Terpening SJ; Kiser R; Mongelli N; Borgia AL; Schultz R; Narayanan V; Bader JP; Rice WG
    Antiviral Res; 1995 Aug; 27(4):335-54. PubMed ID: 8540754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paracyclophanes: a novel class of water-soluble inhibitors of HIV proteinase.
    Ettmayer P; Billich A; Hecht P; Rosenwirth B; Gstach H
    J Med Chem; 1996 Aug; 39(17):3291-9. PubMed ID: 8765512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100.
    De Clercq E
    Mini Rev Med Chem; 2005 Sep; 5(9):805-24. PubMed ID: 16178723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: structure-activity relationship and mechanism of action.
    Witvrouw M; Weigold H; Pannecouque C; Schols D; De Clercq E; Holan G
    J Med Chem; 2000 Mar; 43(5):778-83. PubMed ID: 10715146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human immunodeficiency virus proliferation by macrocyclic polyamines and their metal complexes.
    Inouye Y; Kanamori T; Yoshida T; Bu X; Shionoya M; Koike T; Kimura E
    Biol Pharm Bull; 1994 Feb; 17(2):243-50. PubMed ID: 7515743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential anti-AIDS agents. Synthesis and antiviral activity of naphthalenesulfonic acid derivatives against HIV-1 and HIV-2.
    Mohan P; Singh R; Baba M
    J Med Chem; 1991 Jan; 34(1):212-7. PubMed ID: 1704064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.
    Ross A; Soares DC; Covelli D; Pannecouque C; Budd L; Collins A; Robertson N; Parsons S; De Clercq E; Kennepohl P; Sadler PJ
    Inorg Chem; 2010 Feb; 49(3):1122-32. PubMed ID: 20039648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission.
    Leydet A; Moullet C; Roque JP; Witvrouw M; Pannecouque C; Andrei G; Snoeck R; Neyts J; Schols D; De Clercq E
    J Med Chem; 1998 Dec; 41(25):4927-32. PubMed ID: 9836609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.
    Pauwels R; Andries K; Debyser Z; Van Daele P; Schols D; Stoffels P; De Vreese K; Woestenborghs R; Vandamme AM; Janssen CG
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1711-5. PubMed ID: 7680476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isothiazole derivatives as novel HIV replication inhibitors.
    Cutrì CC; Garozzo A; Pannecouque C; Castro A; Guerrera F; De Clercq E
    Antivir Chem Chemother; 2004 Jul; 15(4):201-5. PubMed ID: 15457681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.